| LLY | Eli Lilly and Co | 8.15% |
| ABBV | AbbVie Inc | 7.91% |
| UNH | UnitedHealth Group Inc | 6.25% |
| JNJ | Johnson & Johnson | 4.92% |
| MRK | Merck & Co Inc | 4.78% |
| AZN.L | AstraZeneca PLC | 4.15% |
| TMO | Thermo Fisher Scientific Inc | 3.28% |
| BMY | Bristol-Myers Squibb Co | 3.17% |
| CVS | CVS Health Corp | 3.11% |
| ABT | Abbott Laboratories | 2.68% |
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
JPMorgan Healthcare Leaders ETF · Issued by JPMorgan
No recent news for JDOC. The ingest cron pulls every 15 minutes during market hours.